Live Breaking News & Updates on Prior To Northwestern University

Published: Mar 02, 2021
 
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development
New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing
Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics
 
a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced the appointment of four new members to its board of directors: June Almenoff, MD, PhD, Michael Davidson, MD, Delcan Doogan, MD, and Stuart Rich, MD. ....

Loyola University Stritch School Of Medicine , United States , Northwestern University , University Of Chicago , University Of Illinois College Medicine , University Of Illinois , Declan Doogan , Anthony Ditonno , Orion Pharma , Michael Davidson , Delcan Doogan , June Almenoff , Board Of Trustees , Prior To Northwestern University , Glasgow University Medical School , Pulmonary Vascular Research Institute , Glasgow University , Product Development , Clinical Research , Sinai School Of Medicine , Research Foundation , Tenax Therapeutics Inc , Phyxius Pharma Inc , Washington University Of St , National Lipid Association , Exchange Commission ,